Literature DB >> 23093619

Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent.

Mattias Enoksson1, Christine Möller-Westerberg, Grzegorz Wicher, Padraic G Fallon, Karin Forsberg-Nilsson, Carolina Lunderius-Andersson, Gunnar Nilsson.   

Abstract

IL-33 is a recently discovered cytokine involved in induction of Th2 responses and functions as an alarmin. Despite numerous recent studies targeting IL-33, its role in vivo is incompletely understood. Here we investigated inflammatory responses to intraperitoneal IL-33 injections in wild-type and mast cell-deficient mice. We found that wild-type mice, but not mast cell-deficient W(sh)/W(sh) mice, respond to IL-33 treatment with neutrophil infiltration to the peritoneum, whereas other investigated cell types remained unchanged. In W(sh)/W(sh) mice, the IL-33-induced innate neutrophil response could be rescued by local reconstitution with wild-type but not with T1/ST2(-/-) mast cells, demonstrating a mast cell-dependent mechanism. Furthermore, we found this mechanism to be partially dependent on mast cell-derived TNF, as we observed reduced neutrophil infiltration in W(sh)/W(sh) mice reconstituted with TNF(-/-) bone marrow-derived mast cells compared with those reconstituted with wild-type bone marrow-derived mast cells. In agreement with our in vivo findings, we demonstrate that human neutrophils migrate toward the supernatant of IL-33-treated human mast cells. Taken together, our findings reveal that IL-33 activates mast cells in vivo to recruit neutrophils, a mechanism dependent on IL-33R expression on peritoneal mast cells. Mast cells activated in vivo by IL-33 probably play an important role in inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093619     DOI: 10.1182/blood-2012-05-434209

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  TGF-β1 Suppresses IL-33-Induced Mast Cell Function.

Authors:  Victor S Ndaw; Daniel Abebayehu; Andrew J Spence; Patrick A Paez; E Motunrayo Kolawole; Marcela T Taruselli; Heather L Caslin; Alena P Chumanevich; Anuya Paranjape; Bianca Baker; Brian O Barnstein; Tamara T Haque; Kasalina N Kiwanuka; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2017-06-21       Impact factor: 5.422

2.  IL-33/ST2 axis promotes mast cell survival via BCLXL.

Authors:  Jun-Xia Wang; Shinjiro Kaieda; Sarah Ameri; Nadia Fishgal; Daniel Dwyer; Anthony Dellinger; Christopher L Kepley; Michael F Gurish; Peter A Nigrovic
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

Review 3.  Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms.

Authors:  Hae Woong Choi; Soman N Abraham
Journal:  Mol Immunol       Date:  2014-03-11       Impact factor: 4.407

4.  Cytokine Production Is Differentially Modulated in Malignant and Non-malignant Tissues in ST2-Receptor Deficient Mice.

Authors:  Celso Tarso Rodrigues Viana; Laura Alejandra Ariza Orellano; Luciana Xavier Pereira; Simone Aparecida de Almeida; Letícia Chinait Couto; Marcela Guimarães Takahashi de Lazari; Silvia Passos Andrade; Paula Peixoto Campos
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

5.  Lactic acid suppresses IgE-mediated mast cell function in vitro and in vivo.

Authors:  Daniel Abebayehu; Andrew J Spence; Heather Caslin; Marcela Taruselli; Tamara T Haque; Kasalina N Kiwanuka; Elizabeth Motunrayo Kolawole; Alena P Chumanevich; Scott A Sell; Carole A Oskeritzian; John Ryan; Sydney Ann Kee
Journal:  Cell Immunol       Date:  2019-04-12       Impact factor: 4.868

6.  Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33.

Authors:  Amit K Mehta; Wei Duan; Astrid M Doerner; Suzanne L Traves; David H Broide; David Proud; Bruce L Zuraw; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2015-06-19       Impact factor: 10.793

7.  The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.

Authors:  Dawn K Reichenbach; Vincent Schwarze; Benjamin M Matta; Victor Tkachev; Elisabeth Lieberknecht; Quan Liu; Brent H Koehn; Dietmar Pfeifer; Patricia A Taylor; Gabriele Prinz; Heide Dierbach; Natalie Stickel; Yvonne Beck; Max Warncke; Tobias Junt; Annette Schmitt-Graeff; Susumu Nakae; Marie Follo; Tobias Wertheimer; Lukas Schwab; Jason Devlin; Simon C Watkins; Justus Duyster; James L M Ferrara; Heth R Turnquist; Robert Zeiser; Bruce R Blazar
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

Review 8.  Interleukin 33 is a guardian of barriers and a local alarmin.

Authors:  Nikolas T Martin; Michael U Martin
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

9.  Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression.

Authors:  Daniel Abebayehu; Andrew J Spence; Amina Abdul Qayum; Marcela T Taruselli; Jamie J A McLeod; Heather L Caslin; Alena P Chumanevich; Elizabeth Motunrayo Kolawole; Anuya Paranjape; Bianca Baker; Victor S Ndaw; Brian O Barnstein; Carole A Oskeritzian; Scott A Sell; John J Ryan
Journal:  J Immunol       Date:  2016-08-24       Impact factor: 5.422

10.  Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity.

Authors:  Anuya Paranjape; Oksana Chernushevich; Amina Abdul Qayum; Andrew J Spence; Marcela T Taruselli; Daniel Abebayehu; Brian O Barnstein; Jamie Josephine Avila McLeod; Bianca Baker; Gurjas S Bajaj; Alena P Chumanevich; Carole A Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2016-07-21       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.